Study of efficacy and safety of everolimus and letrozole in estrogen receptor positive HER2 negative metastatic or locally advanced breast cancer patients

Update Il y a 4 ans
Reference: EUCTR2012-003065-17

Woman Man

  • | Country :
  • -
  • | organs :
  • -
  • | Specialty :
  • -

Extract

The primary objective is to estimate progression-free survival in patients treated with everolimus + letrozole in the first line metastatic setting.


Inclusion criteria

  • Estrogen receptor positive metastatic breast cancer